Share on StockTwits

Neuralstem (NYSE:CUR) Insider Karl Johe sold 6,000 shares of Neuralstem stock in a transaction dated Tuesday, September 2nd. The shares were sold at an average price of $4.09, for a total transaction of $24,540.00. Following the sale, the insider now directly owns 495,747 shares in the company, valued at approximately $2,027,605. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Shares of Neuralstem (NYSE:CUR) traded up 1.09% on Thursday, hitting $3.9427. 181,775 shares of the company’s stock traded hands. Neuralstem has a one year low of $1.60 and a one year high of $4.81. The stock’s 50-day moving average is $3.39 and its 200-day moving average is $3.77. The company’s market cap is $342.4 million.

Neuralstem (NYSE:CUR) last released its earnings data on Friday, August 8th. The company reported ($0.08) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.05) by $0.03. Analysts expect that Neuralstem will post $-0.22 EPS for the current fiscal year.

A number of analysts have recently weighed in on CUR shares. Analysts at Aegis reiterated a “buy” rating on shares of Neuralstem in a research note on Friday, August 8th.

Neuralstem, Inc is a development-stage company focused on the development and commercialization of treatments for central nervous system disease based on transplanting human neural stems cells and the use of small molecule drugs.

Receive News & Ratings for Neuralstem Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neuralstem Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.